Literature DB >> 12488164

Percutaneous excisional breast biopsy.

Anita T Johnson1, Ronda S Henry-Tillman, Lanette F Smith, David Harshfield, Sohelia Korourian, Harry Brown, Sarah Lane, Maureen Colvert, V Suzanne Klimberg.   

Abstract

BACKGROUND: The utility of the vacuum-assisted breast biopsy device (VABB) under stereotactic guidance is well established. We hypothesized that the complete removal of small benign lesions under ultrasonography guidance in an outpatient setting could be obtained with minimal morbidity with the multidirectional hand held vacuum-assisted biopsy.
METHODS: Patients enrolled in this study underwent an ultrasound-guided minimally invasive excisional breast biopsy through a 3-mm incision. Removal of the abnormality was accomplished with a handheld 8- or 11-gauge Mammotome.
RESULTS: Eighty-one patients had 101 lesions excised. The average (+/- SD) age of the participants was 46.8 +/- 15.4 years. The average size of the lesions was 1.15 +/- 0.43 cm (range 0.5 cm to 2.0 cm). Ninety-four lesions (93%) had benign pathology, five lesions (5%) were malignant, and two (2%) lesions had atypical hyperplasia. Six-month baseline mammogram performed in 71% of patients more than 40 years old documented resolution of percutaneously removed lesions.
CONCLUSIONS: Vacuum-assisted excisional breast biopsy under ultrasound guidance is an effective technique for the therapeutic management of benign lesions.

Entities:  

Mesh:

Year:  2002        PMID: 12488164     DOI: 10.1016/s0002-9610(02)01099-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

1.  Ultrasound-guided vacuum-assisted breast biopsy: Use at the European Institute of Oncology in 2010.

Authors:  F Abbate; E Cassano; S Menna; G Viale
Journal:  J Ultrasound       Date:  2011-10-21

Review 2.  Vacuum-assisted breast biopsy for breast cancer.

Authors:  Hai-Lin Park; Jisun Hong
Journal:  Gland Surg       Date:  2014-05

3.  Percutaneous ultrasound-guided vacuum-assisted excision of benign breast lesions: A learning curve to assess outcomes.

Authors:  Juan Pablo Salazar; Ignacio Miranda; Juan de Torres; María N Rus; Martin Espinosa-Bravo; Antonio Esgueva; Rafael Salvador; Isabel T Rubio
Journal:  Br J Radiol       Date:  2018-11-29       Impact factor: 3.039

4.  Feasibility and safety of image-guided vacuum-assisted breast biopsy: A PRISMA-compliant systematic review and meta-analysis of 20 000 population from 36 longitudinal studies.

Authors:  Ming Fang; Guilin Liu; Guoliang Luo; Tianyu Wu
Journal:  Int Wound J       Date:  2019-09-18       Impact factor: 3.315

5.  Ultrasound-guided vacuum-assisted breast biopsy using Mammotome biopsy system for detection of breast cancer: results from two high volume hospitals.

Authors:  Shaobo Pan; Wenguang Liu; Ketao Jin; Yu Liu; Yunxiao Zhou
Journal:  Int J Clin Exp Med       Date:  2014-01-15

Review 6.  The Evolving Role of Vacuum Assisted Biopsy of the Breast: A Progression from Fine-Needle Aspiration Biopsy.

Authors:  Ian C Bennett; Apoorva Saboo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

7.  Feasibility of percutaneous excision followed by ablation for local control in breast cancer.

Authors:  V Suzanne Klimberg; Cristiano Boneti; Laura L Adkins; Maureen Smith; Eric Siegel; Vladimir Zharov; Scott Ferguson; Ronda Henry-Tillman; Brian Badgwell; Soheila Korourian
Journal:  Ann Surg Oncol       Date:  2011-09-09       Impact factor: 5.344

8.  The current role of vacuum assisted breast biopsy system in breast disease.

Authors:  Hai-Lin Park; Lee Su Kim
Journal:  J Breast Cancer       Date:  2011-03-31       Impact factor: 3.588

9.  Analysis of false-negative results after US-guided 14-gauge core needle breast biopsy.

Authors:  Ji Hyun Youk; Eun-Kyung Kim; Min Jung Kim; Jin Young Kwak; Eun Ju Son
Journal:  Eur Radiol       Date:  2009-10-28       Impact factor: 5.315

10.  Nonsurgical management of fibroadenoma and virginal breast hypertrophy.

Authors:  Sandhya Pruthi; Katie N Jones
Journal:  Semin Plast Surg       Date:  2013-02       Impact factor: 2.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.